Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory May 4, 2026 04 May 2026 Acarix Changes Publication Date for Q1 2026 Interim Report Acarix (ticker: Acarix) hereby announces that the company is postponing the release of its interim report for the first quarter of 2026... Continue reading
Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish May 4, 2026 04 May 2026 Acarix ändrar datum för publicering av delårsrapport för Q1 2026 Acarix (ticker: Acarix) meddelar härmed att bolaget flyttar fram publiceringstidpunkten för delårsrapporten för de... Continue reading
Corporate Information, English, IR, News, Other Corporate Information April 7, 2026 07 Apr 2026 ACARIX PRESENTS ABSTRACT AT ACC.26 HIGHLIGHTING CADSCOR® SYSTEM’S DIAGNOSTIC UTILITY COMPARED TO STANDARD STRESS TESTS IN CHEST PAIN PATIENTS Findings demonstrate high NPV, care time savings of up to 40 hours, and cost reductions exceeding $100,000 per inpatient case, reinforc... Continue reading
Corporate Information, English, IR, News, Other Corporate Information February 11, 2026 11 Feb 2026 Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System Malmö, Sweden – Acarix AB (Nasdaq Stockholm: ACARIX), a medical device company advancing noninvasive, AI enabled diagnostics... Continue reading
Corporate Information, English, IR, News, Other Corporate Information February 4, 2026 04 Feb 2026 Acarix Receives EU MDR Certification for the CADScor®System Malmö, Sweden – Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announced that its CADScor Sys... Continue reading
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory December 8, 2025 08 Dec 2025 ACARIX CARRIES OUT A DIRECTED SHARE ISSUE OF APPROX. SEK 33.4 MILLION The Board of Directors of Acarix AB (publ) ("Acarix" or the "Company") has today resolved to carry out a directed share issue of maximu... Continue reading
Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish December 8, 2025 08 Dec 2025 ACARIX GENOMFÖR EN RIKTAD EMISSION OM CIRKA 33,4 MSEK Styrelsen i Acarix AB (publ) (”Acarix” eller ”Bolaget”) har idag beslutat om att genomföra en riktad nyemi... Continue reading
Corporate Information, English, IR, News, Other Corporate Information November 6, 2025 06 Nov 2025 Invitation to presentation of Acarix´s third quarter 2025 report Acarix third quarter result is now released and we invite investors, analysts, and media representatives to join the recorded webcast p... Continue reading
Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish October 24, 2025 24 Oct 2025 Acarix AB byter Certified Adviser till Tapper Partners AB Malmö – Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, meddelar idag att bolaget byter Certified A... Continue reading
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory October 24, 2025 24 Oct 2025 Acarix AB changes Certified Adviser to Tapper Partners AB Malmö, Sweden – Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announce that the company is c... Continue reading
Corporate Information, English, IR, News, Other Corporate Information October 17, 2025 17 Oct 2025 Acarix responds to G-BA decision on reimbursement in the German market Malmö, Sweden – Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announce that G-BA reached a n... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information October 9, 2025 07 Oct 2025 Acarix CADScor® System Gains HealthChoice Reimbursement Coverage Malmö, Sweden – Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, is pleased to announce that HealthCh... Continue reading